Carcinoma in situ of skin of eyelid, including canthus
ICD-10 D04.1 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of eyelid, including canthus.
Carcinoma in situ of the skin of the eyelid, including the canthus, is a non-invasive form of skin cancer characterized by the abnormal growth of cells in the epidermis. This condition is often associated with sun exposure and can manifest as a persistent, non-healing sore, a scaly patch, or a change in the appearance of the skin. The eyelid is a particularly sensitive area, and lesions here can lead to complications if not treated promptly. Diagnosis typically involves a biopsy to confirm the presence of atypical keratinocytes. Surveillance protocols for patients diagnosed with carcinoma in situ of the eyelid include regular dermatological examinations to monitor for any changes in the lesion or the development of new lesions. The risk of progression to invasive carcinoma is present, particularly in cases where the lesion is left untreated or if there are multiple lesions. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy, depending on the size and location of the carcinoma. Early detection and intervention are crucial to prevent progression and ensure optimal outcomes.
Detailed clinical notes including lesion size, location, and biopsy results.
Diagnosis and treatment of skin lesions, follow-up care for skin cancer patients.
Ensure clear documentation of the treatment plan and patient education regarding sun protection.
Notes on visual function and any impact on eyelid movement or appearance.
Management of eyelid lesions, surgical interventions for cosmetic or functional restoration.
Document any potential impact on vision and the need for interdisciplinary care.
Used when excising a carcinoma in situ from the eyelid.
Document the size of the lesion and the method of excision.
Ensure coordination between dermatology and ophthalmology for optimal patient care.
Carcinoma in situ of the eyelid is significant due to its potential to progress to invasive cancer if left untreated. It requires careful monitoring and appropriate treatment to prevent complications.
